Cancer Biomarkers

cancer biomarker refers to a constituent or method that is indicative of the existence of cancer in the body. A biomarker may be a molecule concealed by a tumour or a particular response of the body to the existence of cancer. Epigenetic, proteomic, genetic, glycomic, and imaging biomarkers can be recycled for cancer diagnosis, prognosis, and epidemiology. While some cancer biomarkers can be used to forecast how violently your cancer will grow, and are therefore useful for evaluating your prognosis, the most favourable use of biomarkers today is to recognize which therapies a patient’s cancer may or may not react to.

  • Diagnostic Biomarkers
  • Tumour Suppressors Biomarkers
  • Predictive & Prognostic Biomarkers
  • Companion Biomarker

Related Conference of Cancer Biomarkers

September 16-17, 2024

9th World Conference on Breast and Cervical Cancer

London, UK
September 19-20, 2024

25th World Congress on Cancer Summit

Paris, France
November 25-26, 2024

7th International Conference on Anti-Cancer Drugs & Therapies

Vancouver, Canada
November 28-29, 2024

44th Euro Congress on Cancer Science & Therapy

Paris, France
November 28-29, 2024

14th World Congress on Breast Cancer

Paris, France
December 10-11, 2024

8th Global Meeting on Oncology and Radiology

Dubai, UAE
December 11-12, 2024

34th Experts Meet On Cancer Research & Therapy

Aix-en-Provence, France
March 10-11, 2025

3rd World Congress on Oral Cancer

Paris, France
March 24-25, 2025

25th World Congress on Cancer and Diagnostics

London, UK

Cancer Biomarkers Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in